Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease.

Proceedings of the National Academy of Sciences of the United States of America
Xiuming ZhangAlzheimer’s Disease Neuroimaging Initiative


We used a data-driven Bayesian model to automatically identify distinct latent factors of overlapping atrophy patterns from voxelwise structural MRIs of late-onset Alzheimer's disease (AD) dementia patients. Our approach estimated the extent to which multiple distinct atrophy patterns were expressed within each participant rather than assuming that each participant expressed a single atrophy factor. The model revealed a temporal atrophy factor (medial temporal cortex, hippocampus, and amygdala), a subcortical atrophy factor (striatum, thalamus, and cerebellum), and a cortical atrophy factor (frontal, parietal, lateral temporal, and lateral occipital cortices). To explore the influence of each factor in early AD, atrophy factor compositions were inferred in beta-amyloid-positive (Aβ+) mild cognitively impaired (MCI) and cognitively normal (CN) participants. All three factors were associated with memory decline across the entire clinical spectrum, whereas the cortical factor was associated with executive function decline in Aβ+ MCI participants and AD dementia patients. Direct comparison between factors revealed that the temporal factor showed the strongest association with memory, whereas the cortical factor showed the strongest...Continue Reading


Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Jun 22, 2000·NeuroImage·J Ashburner, K J Friston
Oct 27, 2004·NeuroImage·Stephen M SmithPaul M Matthews
Oct 27, 2004·NeuroImage·Bruce FischlAnders M Dale
Feb 7, 2007·Physical Review Letters·Changsong ZhouJürgen Kurths
Aug 19, 2007·Brain : a Journal of Neurology·Gwenaëlle DouaudAnthony James
Feb 20, 2008·Journal of the International Neuropsychological Society : JINS·Ellen GroberClaudia Kawas
Jul 12, 2008·Annual Review of Psychology·David P Salmon, Mark W Bondi
Sep 12, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Danielle S BassettAndreas Meyer-Lindenberg
Mar 20, 2009·Annals of Neurology·Leslie M ShawUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Sep 11, 2009·Annals of Neurology·Julie A SchneiderDavid A Bennett
Dec 2, 2009·Frontiers in Neuroinformatics·David MeunierEdward T Bullmore
Jun 22, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·Bradford C DickersonUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jun 10, 2011·Journal of Neurophysiology·B T Thomas YeoRandy L Buckner
Jan 18, 2012·NeuroImage·Bruce Fischl
May 31, 2012·Brain Imaging and Behavior·Laura E GibbonsUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jul 12, 2012·Brain Imaging and Behavior·Paul K CraneUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Nov 6, 2012·NeuroImage·Jorge L Bernal-RusielUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jan 11, 2013·Alzheimer's Research & Therapy·Benjamin LamSandra E Black
Mar 13, 2013·Lancet Neurology·Victor L VillemagneUNKNOWN Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group
Nov 19, 2013·Acta Neuropathologica·Keith A JosephsDennis W Dickson
Jul 12, 2014·Brain : a Journal of Neurology·Alexandra L YoungUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Sep 25, 2014·Cerebral Cortex·B T Thomas YeoMichael W L Chee
Mar 19, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·Nienke M E ScheltensWiesje M van der Flier
Aug 12, 2015·Human Brain Mapping·Rik OssenkoppeleGil D Rabinovici
Oct 8, 2015·Journal of Alzheimer's Disease : JAD·Jean-Philippe CoutuUNKNOWN Alzheimer's Disease Neuroimaging Initiative (ADNI)
Nov 26, 2015·Proceedings of the National Academy of Sciences of the United States of America·Maxwell A BertoleroMark D'Esposito
Dec 1, 2015·PloS One·Min Soo ByunUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Mar 11, 2016·Brain : a Journal of Neurology·Rik OssenkoppeleGil D Rabinovici
Apr 26, 2016·Neuropsychology·Robert S WilsonPatricia A Boyle

❮ Previous
Next ❯


May 19, 2017·Current Opinion in Neurology·Neil P OxtobyUNKNOWN EuroPOND consortium
Dec 1, 2017·Der Nervenarzt·D BzdokF Schneider
Oct 24, 2018·Brain : a Journal of Neurology·Mara Ten KateUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
May 12, 2019·GigaScience·Angela TamUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Nov 30, 2018·Brain : a Journal of Neurology·Magdalena A Kolanko, Paresh A Malhotra
Jan 1, 2020·Brain : a Journal of Neurology·AmanPreet BadhwarPierre Bellec
Oct 16, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Dallas P VeitchUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Oct 17, 2018·Nature Communications·Alexandra L YoungUNKNOWN Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Nov 2, 2019·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Rik OssenkoppeleOskar Hansson
Oct 27, 2017·Neurology·Shannon L RisacherUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Nov 23, 2017·Frontiers in Neurology·Neil P OxtobyUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Nov 7, 2017·Frontiers in Neuroscience·Andreia V FariaSusumu Mori
Aug 22, 2017·Frontiers in Human Neuroscience·Christopher R Madan
Jul 29, 2019·Alzheimer's Research & Therapy·Leonardino A DigmaUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Aug 9, 2018·Alzheimer's Research & Therapy·Niklas MattssonOskar Hansson
Apr 8, 2020·Neuroinformatics·Yanshuai TuUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jan 14, 2021·Brain : a Journal of Neurology·Betty M TijmsPieter Jelle Visser
Feb 2, 2021·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Dorene M Rentz, Kathryn V Papp
Feb 21, 2021·Alzheimer's Research & Therapy·Fedor LevinUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Mar 24, 2020·Biological Psychiatry·Mohamad HabesChristos Davatzikos
Jun 20, 2020·Biological Psychiatry·Seok-Jun HongAdriana Di Martino
Mar 9, 2021·Journal of Alzheimer's Disease : JAD·Baiwen ZhangShuicai Wu
Jul 26, 2019·NeuroImage·Nanbo SunUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Nov 10, 2018·NeuroImage. Clinical·Xiuchao SuiUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Feb 20, 2018·Neurobiology of Aging·Konstantinos PoulakisEric Westman
Aug 9, 2020·NeuroImage·Minh NguyenUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jan 22, 2021·Physiological Reviews·Camilla Ferrari, Sandro Sorbi
Jun 4, 2021·Cerebral Cortex·Boris-Stephan RauchmannUNKNOWN DELCODE study group and the Alzheimer's Disease Neuroimaging Initiative (ADNI)
Aug 31, 2021·Frontiers in Artificial Intelligence·Alexandra L YoungUNKNOWN Alzheimer’s Disease Neuroimaging Initiative

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.